Welcome to IDEA Collider with your host, Rick Ritacco.
In this episode, we sit down with Sue Wood, a senior expert at IDEA Pharma with a PhD from Oxford and decades of experience translating complex scientific concepts into relevant narratives. Sue discusses the unique challenges biotechs face with early positioning, explaining why teams often struggle with the paradox of having immediate scientific certainty about a molecule but immense clinical uncertainty about its future.
We explore how to simplify scientific messaging without "dumbing it down," and Sue shares three proven strategies: reappropriating non-pharma nomenclature, evolving familiar drug classes, and focusing on tangible clinical outcomes. Sue also highlights the importance of cross-functional alignment, noting that a team's conviction to execute a narrative often matters more than having absolute precision.
Tune in to hear her hilarious origin story involving the Boston Globe and oat bran donuts, and learn actionable advice on what biotechs should immediately remove from their websites.
Don't forget to Like, Share, Subscribe, Rate, and Review!
Keep up with Sue Wood; LinkedIn: https://www.linkedin.com/in/susan-wood-266631244/
Follow IDEA Pharma On; Website: https://www.ideapharma.com/
Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/